Open Access

Oral anticoagulation, thrombosis and bleeding – Improving patient care with NOACs

Event: ESC CONGRESS 2016
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium
Sponsored by Bristol-Myers Squibb and Pfizer Alliance
Date: 28 August 2016
Time: 18:30 - 20:00

Congress Session

6 presentations in this session

Improving patient care with NOACs – Where are we now?

Speaker: Doctor F. Andreotti (Rome, IT)
Thumbnail

Thrombosis versus bleeding risk in NVAF patients – From trials to clinical practice.

Speaker: Professor G. Lip (Liverpool, GB)
Thumbnail

Oral anticoagulation – Managing challenging patients with NVAF.

Speaker: Professor H. Darius (Berlin, DE)
Thumbnail

Can evidence from VTE treatment trials with NOACs inform the cardiologist?

Speaker: Doctor A. Cohen (London, GB)
Thumbnail

Are there more NVAF patients that would benefit from anticoagulation with a NOAC?

Speaker: Doctor J. Healey (Hamilton, CA)
Thumbnail

Optimising patient care with NOACs – Panel discussion.

Speaker: Professor H. Darius (Berlin, DE)
Speaker: Doctor F. Andreotti (Rome, IT)
Thumbnail

7 speakers from this session

Doctor Felicita Andreotti

Fondazione Policlinico Universitario Gemelli IRCCS, Catholic University, Rome (Italy)
19 presentations
0 follower

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
70 presentations
3 followers

Professor Harald Darius

Vivantes Neukoelln Medical Center, Berlin (Germany)
10 presentations
0 follower

Doctor Alexander Thomas Cohen

Guy's and St Thomas' NHS Trust Hospitals, London (United Kingdom of Great Britain & Northern Ireland)
12 presentations
0 follower

Doctor Jeff Healey

Population Health Research Institute, Hamilton (Canada)
12 presentations
0 follower

Professor Harald Darius

Vivantes Neukoelln Medical Center, Berlin (Germany)
10 presentations
0 follower

Doctor Felicita Andreotti

Fondazione Policlinico Universitario Gemelli IRCCS, Catholic University, Rome (Italy)
19 presentations
0 follower

This platform is supported by

logo Novo Nordisk